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Background: Eosinophil cationic protein is a clinical asthma biomarker that would be released into blood,
especially gathered in bronchia. The signal peptide of eosinophil cationic protein (ECPsp) plays an important role in
translocating ECP to the extracellular space. We previously reported that ECPsp inhibits microbial growth and
regulates the expression of mammalian genes encoding tumor growth factor-α (TGF-α) and epidermal growth
factor receptor (EGFR).
Results: In the present study, we first generated a DNA microarray dataset, which showed that ECPsp upregulated
proinflammatory molecules, including chemokines, interferon-induced molecules, and Toll-like receptors. The levels
of mRNAs encoding CCL5, CXCL10, CXCL11, CXCL16, STAT1, and STAT2 were increased in the presence of ECPsp by
2.07-, 4.21-, 7.52-, 2.6-, 3.58-, and 1.67-fold, respectively. We then constructed a functional linkage network by
integrating the microarray dataset with the pathway database of Kyoto Encyclopedia of Genes and Genomes
(KEGG). Follow-up analysis revealed that STAT1 and STAT2, important transcriptional factors that regulate cytokine
expression and release, served as hubs to connect the pathways of cytokine stimulation (TGF-α and EGFR pathways)
and inflammatory responses. Furthermore, integrating TGF-α and EGFR with the functional linkage network
indicated that STAT1 and STAT2 served as hubs that connect two functional clusters, including (1) cell proliferation
and survival, and (2) inflammation. Finally, we found that conditioned medium in which cells that express ECPsp
had been cultured could chemoattract macrophages. Experimentally, we also demonstrated that the migration of
macrophage could be inhibited by the individual treatment of siRNAs of STAT1 or STAT2. Therefore, we
hypothesize that ECPsp may function as a regulator for enhancing the migration of macrophages through the
upregualtion of the transcriptional factors STAT1 and STAT2.
Conclusion: The increased expression and release of various cytokines triggered by ECPsp may attract
macrophages to bronchia to purge damaged cells. Our approach, involving experimental and computational
systems biology, predicts pathways and potential biological functions for further characterization of this novel
function of ECPsp under inflammatory conditions.
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Human eosinophil cationic protein (ECP) is an import-
ant molecule related to diseases such as asthma and in-
flammation. It is secreted by activated eosinophils and
serves as one of the major components of eosinophil
granule proteins [1]. Structurally, ECP contains three α-
helices, five β-strands, and eight loops [2], with a mo-
lecular mass of 16–22 kDa, depending on the extent of
post-translational modification [3,4]. Also called ribo-
nuclease 3 (RNase3), ECP belongs to the human RNaseA
superfamily, members of which have very low ribonu-
cleolytic activity but high cytotoxic activity [5]. Members
of the RNaseA superfamily are defined by their similar
sequences and structures, and their ribonucleolytic activ-
ity regulates gene expression at the mRNA level [6]. To
date, 13 human protein sequences have been found to
be similar to bovine pancreatic RNaseA [7-10]. The 19
arginine and 2 lysine residues in the primary sequence
of ECP account for its high isoelectric point (pI = 10.8)
[11,12]. The highly positive charge carried by ECP con-
tributes to its cytotoxic activity, as it facilitates inter-
action between ECP and negatively charged molecules,
such as heparin sulfate and cell membrane lipids [11,13].
Through its interaction with carbonhydrate on cell
surface, ECP translocates into cells by endocytosis and
causes cell damage [13]. This may contribute to airway
inflammation during asthma and to damage of the intes-
tinal mucosa in Crohn’s disease [14-16]. The role of ECP
in responding to pathogen infection by contributing to
innate immune defenses through the removal of invad-
ing microorganisms is well documented. The protein is
also cytotoxic to parasites, bacteria, viruses, helminths,
and mammalian cells [15,17-19]. Therefore, ECP has
been categorized as an antimicrobial peptide (AMP).
The mechanism of ECP-triggered cell damage is sug-
gested to involve destabilization of cell membrane lipids
through pore formation, causing changes in membrane
permeability and membrane leakage [5,12,20].
Human ECP possesses a 27-amino-acid signal peptide
that is cleaved from the rest of the protein by a signal
peptidase (SP) in the endoplasmic reticulum (ER). The
signal peptide of ECP (ECPsp), which comprises a short,
positively charged N-terminal region, a central hydro-
phobic region, and a polar C-terminal region, leads to
the secretion of ECP into the extracellular space. The
cytotoxicity of ECPsp inhibits the growth of lower
organisms, such as Escherichia coli and Pichia pastoris,
but not that of mammalian cells [21]. This growth inhib-
ition results from the suppression of de novo protein
synthesis. Cell growth is restored when signal peptide
peptidase (SPP) and ECPsp are co-expressed in P. pas-
toris [21]. Cleavage of ECPsp into the ECPsp-1-17 and
ECPsp-18-27 fragments by SPP eliminates the cytotox-
icity, thus preventing damage to mammalian cells.Furthermore, knockdown of the SPP mRNA level in
mammalian cells restored the inhibitory effect of ECPsp
on cell proliferation [21].
Moreover, in 2007 we reported ECPsp-1-17 enhances
the expression of tumor growth factor-alpha (TGF-α)
and epidermal growth factor receptor (EGFR) at both
the mRNA and protein levels in A431 and HL-60 cell
lines [22]. Therefore, ECPsp may possess dual functions
involving both protein secretion and the regulation of
gene expression. In this study, we use a systems biology
approach to further characterize the biological function
(s) of ECPsp. In particular, we used DNA microarray
analysis to investigate the ECPsp-triggered gene expres-
sion and to characterize the genome-wide interactome
of ECPsp. By combining these two datasets, we explored
the integrated network from STRING 9.0 and KEGG to
identify potential pathways and functional clusters to
profile ECPsp-induced gene expression. Finally, we used
a cell migration assay to demonstrate the novel functions
of ECPsp that were discovered using the systems biology
approaches.
Results
Inflammatory molecules upregulated by ECPsp are central
in the functional linkage network
To understand the gene expression profile triggered by
ECPsp, we used DNA microarray technology to analyze
the transcriptome. All microarray analyses were con-
ducted by Phalanx Biotech (Taiwan). Each total RNA,
derived from the cells transfected with control plasmids
or plasmids containing ECPsp, was duplicated on the
array. We performed two technical replicates of all
experiments to confirm the data and account for experi-
mental variations. According to the gene expression
data, 93 genes were upregulated by more than twofold
with a statistics p value less than 0.05 in ECPsp-
expressing cells relative to controls (Table 1). The 93
genes were submitted to the functional linkage network
obtained from the STRING 9.0 database, and a network
was generated by choosing the default setting (Figure 1).
Within this sub-network, a clearly evident area of
dense interconnections contains nodes that are related
to inflammatory responses. These include chemokines,
interferon-induced/related molecules, and inflammatory
receptors, such as Toll-like receptors. The focused area
thus reveals that ECPsp may induce the expression of
genes that encode proinflammatory molecules for trig-
gering inflammatory pathways. This discovery is crucial
to understanding the biological function of ECPsp. The
function of ECPsp as a conventional signal peptide for
the secretion of mature ECP is well documented [23].
We used differential display technique and real-time RT-
PCR to demonstrate that ECPsp induces TGF-α and
EGFR overexpression [22]. Another study indicated that
Table 1 Genes induced by ECPsp more than twofold
relative to the control
Gene Symbol Fold p-value Gene symbol Fold p-value
IFI44L 5.627 6.13E-04 FZD4 2.470 4.53E-06
CMPK2 5.477 5.24E-07 SULF1 2.455 8.71E-03
RSAD2 5.401 2.36E-06 TNFRSF8 2.452 4.53E-04
CXCL11 5.269 1.02E-04 IFIT5 2.439 3.46E-04
CCL5 4.823 6.01E-05 IFI30 2.431 3.64E-03
ANGPT1 4.542 1.11E-05 EGR1 2.423 6.42E-05
TNFSF10 4.531 2.63E-04 IFI35 2.413 1.26E-03
SAMD9L 4.208 6.56E-08 VCAM1 2.412 8.27E-04
IFIH1 4.199 3.38E-08 GBP1 2.397 4.11E-10
ISG20 4.169 1.14E-04 FGF2 2.385 2.62E-15
IDO1 3.956 1.50E-04 IFI16 2.360 4.28E-06
OAS1 3.919 2.71E-03 STAT1 2.350 2.85E-06
TLR3 3.908 2.72E-07 PLSCR1 2.331 4.79E-05
MX2 3.860 5.31E-04 IRF7 2.305 3.98E-03
CXCL10 3.827 6.56E-10 CD7 2.304 2.87E-04
HERC5 3.783 2.17E-07 IFI27 2.285 3.08E-02
RASGRP3 3.745 2.65E-05 DHX58 2.276 5.73E-04
OAS2 3.695 1.56E-04 PLCG2 2.251 6.55E-07
DDX58 3.596 5.24E-09 UBE2L6 2.248 8.97E-04
XAF1 3.522 1.65E-04 IFI6 2.243 3.62E-02
IFIT2 3.496 2.09E-09 BST2 2.222 2.91E-02
GPR109B 3.435 6.36E-05 NCF2 2.216 1.03E-13
LAMP3 3.295 3.38E-04 ZC3HAV1 2.210 4.61E-06
GBP4 3.194 1.68E-07 PLCB4 2.204 3.35E-10
OASL 3.074 1.79E-05 EDN1 2.204 4.94E-02
HERC6 3.027 8.91E-06 C1R 2.203 4.43E-02
TRIM22 2.961 6.67E-08 COL1A2 2.193 3.44E-03
USP18 2.952 8.08E-04 SP100 2.185 3.74E-08
SP110 2.941 1.82E-06 PARP12 2.185 3.27E-05
MX1 2.891 9.80E-04 GRB10 2.177 5.06E-10
IFI44 2.863 8.60E-08 TLR2 2.163 1.86E-03
PARP9 2.859 8.82E-03 ISG15 2.148 4.58E-04
IFIT1 2.843 1.36E-04 DTX3L 2.134 3.69E-06
IFIT3 2.819 1.91E-04 IFNB1 2.122 4.83E-05
OLR1 2.811 8.00E-05 UBA7 2.116 1.62E-02
TMEM140 2.802 2.26E-04 TYMP 2.105 2.76E-02
HSH2D 2.786 1.43E-02 NT5C3 2.097 2.00E-05
TRANK1 2.759 5.27E-04 GMPR 2.080 1.90E-04
PARP14 2.741 3.27E-07 OAS3 2.069 6.65E-04
STAT2 2.687 2.46E-05 AIM2 2.060 2.46E-07
CASP1 2.678 2.02E-03 CXCL16 2.046 9.54E-04
IFITM1 2.660 4.49E-03 PRSS23 2.028 6.38E-12
CEACAM1 2.612 4.38E-05 TRIM5 2.010 1.12E-03
Table 1 Genes induced by ECPsp more than twofold
relative to the control (Continued)
NEDD9 2.529 1.75E-03 STON2 2.009 1.13E-02
RARRES3 2.520 4.00E-08 C4A 2.006 3.18E-02
EPSTI1 2.484 3.17E-03 C4B 2.006 3.18E-02
CFB 2.470 2.39E-02
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mammalian cells [21]. These findings demonstrated that
ECPsp regulates gene expression in addition to executing
its conventional function, protein secretion.
Patients with asthma usually experience severe inflam-
mation in the respiratory tract. The activated eosinophils
that gather in the airways release mature ECP, which in
turn damages bronchial epithelial cells. At the same
time, it is possible that ECPsp might induce and release
cytokines and chemokines to attract immune cells, such
as T cells, NK cells, eosinophils and macrophages.
To explain the ontology of the functional network,
Network Ontology Analysis (NOA) which applied the
categories of Gene Ontology to network analysis [24]
would be employed. In the NOA results, the category
‘biological process’ is related to inflammation that is
involved in the immune response, including viral infec-
tion and biotic stimulation. The ‘cellular component’ is
consistent with the extracellular release of cytokines,
chemokines, and interferons. Finally, the ‘molecular
function’ is related to the production of chemokines and
cytokines and activation of the JAK/STAT (signal trans-
ducers and activators of transcription) signaling pathway,
which is involved in interferon signaling and chemokine
production (Table 2) [25]. To confirm the upregulation
of molecules related to chemokine and JAK/STAT sig-
naling, the mRNA levels of CCL5, CXCL10, CXCL11,
CXCL16, STAT1, and STAT2 were measured by semi-
quantitative RT-PCR. Indeed, levels of mRNAs encoding
CCL5, CXCL10, CXCL11, CXCL16, STAT1, and STAT2
were upregulated 2.07-, 4.21-, 7.52-, 2.6-, 3.58-, and
1.67-fold, respectively, in cells that expressed ECPsp-
eGFP as compared with cells that expressed eGFP only
(Figure 2).Integrating insights into ECPsp-mediated gene induction
with knowledge of TGF-α/EGFR signaling
We previously demonstrated that ECPsp induced TGF-α
and EGFR expression at the mRNA and protein levels in
A431 cells [22]. The growth factor TGF-α is one of the
ligands that stimulates EGFR phosphorylation and trig-
gers the signaling pathways downstream of this event.
Since the analysis of the KEGG database revealed that
the STAT pathway is triggered by TGF-α via EGFR,
resulting in cell proliferation, cell survival, migration and
Figure 1 Functional linkage network of ECPsp-induced genes. The nodes in the network are the ECPsp-induced genes for which their
expression in ECPsp-eGFP/BEAS-2B cells was at least twofold that in the control eGFP/BEAS-2B (also see Table 1). The edges in the network are
modified from STRING.
Table 2 The top four functional linkage networks identified by NOA
Gene ontology GO: Term p-value Term name
Biological process GO:0009615 2.1E-24 response to virus
GO:0009607 1.3E-20 response to biotic stimulus
GO:0051707 9.7E-20 response to other organism
GO:0002376 4.3E-19 immune system process
Cellular component GO:0005615 1.8E-6 extracellular space
GO:0005737 9.7E-6 cytoplasm
GO:0044421 1.0E-4 extracellular region part
GO:0005576 0.0023 extracellular region
Molecular function GO:0005062 3.0E-6 hematopoietin/interferon-class
(D200-domain) cytokine receptor
signal transducer activity
GO:0016763 4.9E-6 transferase activity, transferring
pentosyl groups
GO:0003950 1.1E-5 NAD+ ADP-ribosyltransferase activity
GO:0008009 1.2E-4 chemokine activity
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Figure 2 Upregulation of proinflammatory molecules in BEAS-2B cells. The levels of mRNAs that encode CCL5, CXCL10, CXCL11, CXCL16,
STAT1, and STAT2 were monitored using semi-quantitative RT-PCR. A gel showing the results from one representative experiment is shown on
the left. The relative level was determined by normalization against the level of mRNA encoding GAPDH, using IMageJ software. The average,
with standard deviation, was derived from three independent experiments. * p <0.05; ** p <0.01.
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http://www.biomedcentral.com/1752-0509/6/105invasion, and the STATs could be activated by chemo-
kines and chemokine receptors and then drive the ex-
pression of cytokine-encoding genes, we hypothesized
that STATs may serve as key transcriptional regulators
in the inflammatory response triggered by ECPsp. Thus,
incorporation of TGF-α, EGFR, and the ECPsp-induced
genes may enable the discovery of new regulatory net-
works initiated by ECPsp. To reduce the complexity of
this analysis, the area of dense interconnections in Figure 1
was extracted and combined with TGF-α and EGFR sig-
naling pathway components.
The area of dense interconnections was determined
manually, which was enlarged and extracted from a seed
of IFNB1 to the borders of a proinflammatory molecule
and a non-proinflammatory molecule. There are 40
nodes in the area of dense interconnections. After their
incorporation, the resulting network showed that the
TGF-α/EGFR pathway connected with inflammatory
molecules via STAT1 and STAT2, important transcrip-
tional factors that regulate cytokine expression and re-
lease (Figure 3) [26]. Therefore, ECPsp may initiate
alternative inflammatory responses in cells when ECP is
expressed simultaneously at asthma/inflammatiory con-
dition. In addition, within these 41 nodes, 9 (CEA-
CAM1, PLCG2, EGR1, GRB10, CASP1, FGF2, ANGPT1,
and TNFSF10) were not related with inflammatory
responses. However within the 9 nodes, 7 (CEACAM1,
PLCG2, EGR1, GRB10, CASP1, FGF2, ANGPT1) were
located within the TGF-α/EGFR pathway network and
these nodes functioned as cell proliferation, angiogen-
esis, and apoptosis, corresponding to the proposed func-
tions of this subnetwork. The other two nodes,
TNFSF10 and DDX58, were not proinflammatory mol-
ecule within the proinflammation network composedwith 34 genes. Thus we concluded that within the proin-
flammation network, 94.12% (32/34) of nodes were
inflammation-related ones.
Since it is hypothesized that STAT1 and STAT2 might
serve as key regulators between the subnetworks in
BEAS-2B cells, we also investigated the mRNA and pro-
tein levels of STAT1 and STAT2 in A431 cells in which
the TGF-α and EGFR are upregulated by ECPsp. If the
STAT1 and STAT2 also upregulated by ECPsp, it is
confident to merge the TGF-α/EGFR signaling network
and the proinflammatory network. As shown in Add-
itional file 1: Figure S1, the levels of mRNAs of STAT1
and STAT2 were increased in the presence of ECPsp by
1.67- and 1.57-fold, respectively, as well as the protein
level by 1.54- and 2.72- fold, respectively. These results
indicated that STATs might serve as real hubs to con-
nect two subnetworks and regulate the gene expression
induced by ECPsp.STAT1 and STAT2 serve as hubs that connects TGF-α
pathways and cytokine/chemokine production
To obtain a high-confidence network, we further studied
the molecules that were induced by ECPsp by more than
fourfold. The underlying functional linkage network is
shown in Figure 4. The functional linkage network was
combined with the current knowledge of TGF-α, EGFR,
and STAT1/2 signaling. As shown in Figure 4, STAT1
and STAT2 still serve as hubs that connect two func-
tional clusters. One cluster contains interferon-inducing
factors and chemokines, such as IFI44L, IFIH1, CCL5,
and CXCL11. Another cluster comprises molecules
related to cell growth and proliferation, such as TGF-α
and EGFR. This network provides potentially valuable
Figure 3 Proposed functional network combining features of the focused ECPsp network with TGF-α and EGFR signaling components.
To connect the data obtained using gene expression profiling with additional experimental data, we selected molecules from the area of dense
interconnections in Figure 1 and incorporated these with known features of TGF-α and EGFR signaling.
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tions of ECPsp.
Medium conditioned by ECPsp-expressing cells causes
migration of RAW 264.7 cells
Our observation that the expression of genes encoding
the chemokines CCL5, CXCL10, CXCL11, and CXCL16
is induced by ECPsp suggests that cells expressing
ECPsp may induce chemoattraction. Among these four
chemokines, some may be responsible for novel bio-
logical functions of ECPsp. Several reports show that
CXCL10 [27], CXCL11 [28], and CXCL16 can initiate
the homing of Th1 cells, NK cells, and eosinophils [29]and that CCL5/RANTES attracts macrophages and eosi-
nophils [30-33]. We assayed macrophage migration
using the human macrophage-like cell line RAW 264.7
to investigate whether the cytokines produced by ECPsp
regulate the recruitment of immune cells. Compared
with medium conditioned by culturing ECPsp/BEAS-2B
and eGFP/BEAS-2B cells, the respective rates of
chemoattractant-mediated macrophage migration were
2.93- and 3.11-fold higher, respectively, for medium con-
ditioned by cells expressing ECPsp-eGFP (Figure 5).
Given that ECPsp is expressed by activated eosinophils
at sites of inflammation or infection, secretory chemo-
kines might attract macrophages to eliminate damaged
Figure 4 STAT1 interconnects genes with high expression levels, TGF-α and EGFR. Genes with a greater than fourfold increase in
expression in the presence of ECPsp are indicated by dark blue circles, whereas STAT1/2 are indicated by light blue circles, and TGF-α and EGFR
are indicated by red circles.
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http://www.biomedcentral.com/1752-0509/6/105cells or pathogens. This is the first time that ECPsp has
been proposed to function not only in secretion but also
in assisting immune-cell migration. In order to demon-
strate whether STAT1 and STAT2 serve as key tran-
scriptional regulators or not experimentally, the
individual siRNA against STAT1 or STAT2 was trans-
fected into BEAS-2B cells which express eGFP or
ECPsp-eGFP. Figure 6 reveals that while the mRNA and
protein levels of STAT1 and STAT2 were knocked down,
the migration of macrophages, which was induced by
ECPsp, was downregulated by 2.38- and 2.50-fold, re-
spectively. It indicated that the migration of macro-
phages enhanced by ECPsp was indeed regulated via
STAT1 and STAT2. It might reflect our hypothesis that
the STAT1 and STAT2 serve as hubs to regulate the
gene expression of chemokines and cytokines in the
ECPsp/BEAS-2B cells.
Discussion
In this study, we generated the functional network using
STRING combined with KEGG. Additionally, we also
analyzed the 93 genes using the network dataset gener-
ated by Cui and colleagues [34]. Cui’s dataset, including
1,634 genes, is comprehensive for analyzing signaling
pathways in cancers. However, only 15 genes overlap
with our 93 genes. The signaling network could not be
generated using these 15 genes. It may be due to our
dataset is related with proinflammatory effects and Cui’s
dataset is focused on cancer signaling.
Under asthmatic conditions, ECP would be released by
activated eosinophils and damage bronchial epithelial
cells. At the same time, ECPsp is cleaved by human SP
and SPP, and the resulting ECPsp triggers overexpression
of TGF-α and EGFR. It suggested that the short signal
peptide of ECP might function not only in protein secre-
tion but also to regulate gene expression [22]. Similarly,
the signal peptide may provide other functions besidesprotein targeting. Localization of the signal peptide of the
envelope glycoprotein (Env) of Jaagsiekte sheep retrovirus
to the nucleus regulates viral gene expression by mediat-
ing a beneficial post-translational step in the replication
cycle [35]. In addition, interaction of calmodulin with the
signal peptide fragments of preprolactin and HIV-1
gp160 processed by SPP triggers Ca2+/calmodulin-
dependent cellular signaling [36].
Our study provides evidence that ECPsp does indeed
regulate gene expression in cells and that the upregulated
genes participate in inflammation-related processes.
Under inflammatory conditions, eosinophils might re-
lease cytokines to stimulate cell growth and activate im-
mune cells; they might release chemokines to attract
macrophages to the bronchia to eliminate the pathogens
and damaged cell debris after secretion of ECP. The
present microarray profiles show the upregulation of four
chemokines, namely CCL5, interferon-induced protein
of 10 kDa (IP-10/CXCL10), interferon-inducible T-cell
alpha chemoattractant (I-TAC/CXCL11), and CXCL16.
Also called RANTES, the chemotactic cytokine CCL5 is
the most potent of these four chemokines, as it is able
to both recruit eosinophils to tissues (via binding to
CCR3) and attract macrophages (via CCR5), Th1 cells,
and basophils to the site of inflammation [30-33]. More-
over, CXCL10 binds CXCR3 and enrolls Th1 cells to re-
sist intracellular pathogen infection, such as viruses [27].
In addition, CXCL10 is an important contributor to air-
way hyperactivity [37]. Another ligand of CXCR3,
CXCL11, attracts Th1 cells, NK cells, and eosinophils to
inflammatory sites [28]. The cytokine CXCL16 interacts
with CXCR6 on Th1 and CD8 effector T cells and plays
a crucial role in recruiting these cells to sites of inflam-
mation [29]. Apart from the molecules mentioned above,
we observed IFN-β and many interferon-related mole-
cules in the dataset generated by DNA microarray ana-
lysis. Interferons have several functions in common,
Figure 5 (See legend on next page.)
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Figure 5 Migration of RAW 264.7 cells is increased in ECPsp-conditioned medium. The macrophages were chemoattracted by serum free
medium (SFM, upper left), conditioned medium culturing BEAS-2B cells (Ctrl, lower left), conditioned medium culturing eGFP/BEAS-2B cells (eGFP,
upper right) and conditioned medium culturing ECPsp-eGFP/BEAS-2B (ECPsp-eGFP, lower right). The folds of migrating RAW 264.7 cells is
increased in ECPsp-conditioned medium by 2.93- and 3.11-fold relative to medium conditioned by BEAS-2B and eGFP/BEAS-2B cells, respectively.
The average, with standard deviation, was derived from three independent experiments. *** p <0.001.
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http://www.biomedcentral.com/1752-0509/6/105many of which involve anti-viral and anti-tumor activ-
ities. By interacting with their specific receptors, interfer-
ons can activate signaling pathways transmitted by
STAT proteins. The STATs (STAT1–STAT6) are a family
of transcriptional factors that regulate the expression ofFigure 6 Knockdown of STAT1 and STAT2 results in the decrease of m
and STAT2 (B) was knocked down using individual siRNA. The fold of migra
BEAS-2B cells cotransfected with ECPsp-eGFP and STAT1 or STAT2 siRNA by
respectively. The average, with standard deviation, was derived from threeparticular immunoregulatory genes. They can be acti-
vated by type I (IFN-α and IFN-β), type II (IFN-γ), and
type III (IFN-λ) interferons [38,39]. For example, type-I
IFNs can induce gene expression via either the ISRE
(interferon-sensitive response element) or GAS (gammaigration of RAW 264.7 cells. The protein expression of STAT1 (A)
ting RAW 264.7 cells is decreased in the medium conditioned by
2.38- and 2.50-fold relative to medium conditioned by BEAS-2B,
independent experiments. * p <0.05; ** p <0.01.
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http://www.biomedcentral.com/1752-0509/6/105interferon activation site) transcription elements through
the actions of the STAT1/STAT2 heterodimer. In con-
trast, type II IFNs can transactivate a gene only if it con-
tains the GAS element by means of the STAT1
homodimer [25,39].
In our DNA microarray dataset, the IFNB1 (IFN-β)
gene is upregulated 80%. It belongs to the type I IFNs
which can activate the JAK/STAT1 and STAT2 pathways
to regulate the expression of genes encoding chemokines
that act downstream in this pathway. We thus suggested
that ECPsp may regulate chemokine production by this
pathway. Transcriptomic analyses indicate that the upre-
gulation of JAK-STAT1 signaling plays a crucial role in
protecting against microbial infection [40,41] by enhan-
cing the expression of genes encoding chemokines
(CXCL1, CXCL2, CCL2, and CCL5), a cytokine (IL-6),
and components of JAK-STAT1 signaling (IFN regula-
tory factor 7 [IRF7], IRF9, and STAT1) [42]. Similarly,
our investigation showed that genes including IRF7,
IFN-induced protein with tetratricopeptides (IFIT1,
IFIT2, IFIT3, and IFIT5), myxovirus resistance 1 and 2
(MX1 and MX2), and 20,50-oligoadenylate synthetases
(OAS1, OAS2, OAS3, and OASL) are upregulated by
ECPsp. In all of these instances, transactivation may de-
pend on JAK/STAT signaling. Therefore, we hypothe-
sized that under inflammatory conditions, eosinophils
release ECP to damage pathogens and that ECPsp simul-
taneously induces JAK/STAT signaling to protect host
cells from microbial infection and trigger chemokine
production that might recruit immune cells, such as
macrophages, to inflammatory sites.Conclusion
We report a potential new function for ECPsp, which
involves the secretion of proinflammatory molecules to
promote the migration of macrophages to sites of in-
flammation. This finding provides clues for researchers
to study the roles of ECP and ECPsp under inflamma-
tory conditions. We propose that ECPsp may serve as
an effector to induce proinflammatory gene expression
and to trigger the recruitment of immune cells, thus
eliminating pathogens, removing damaged cells, and
repairing bronchial epithelial cells via JAK/STAT
signaling.Methods
Cells and cell culture
We cultured the human bronchial epithelial cell line
BEAS-2B (ATCC CRL-9609) and the mouse macrophage
RAW 264.7 cell line in RPMI-1640 (Invitrogen, USA)
supplemented with 10% FBS. Human epidermoid carcin-
oma cell line A431 was cultured in DMEM (GIBCO)
supplemented with 10% heat-inactivated fetal bovineserum. All cells were cultured at 37°C in an incubator
under 5% CO2 and 95% air.
Transfection
The plasmids pEGFPC1 and pEGFPN1-ECPsp were in-
dividually transfected into BEAS-2B cells using Turbo-
FectTM (Thermo Fisher Scientific Inc., USA). For the
transfection, 2 × 106 BEAS-2B or A431 cells were seeded
onto a 100-mm culture plate. After 24 h in culture (~80-
90% confluency), 3 μg of plasmid DNA and 6 μl of Tur-
boFectTM reagent were mixed in 1 ml of serum-free
RPMI-1640. The transfection mixture was gently vor-
texed and incubated for 15 min at room temperature to
allow the formation of transfection complexes. The 1-ml
transfection mixture was then added drop-wise to the
cells and incubated at 37°C for another 48 h, at which
point the cells were harvested for RNA isolation and
Western blotting.
For plasmid and siRNA co-transfection, 3 × 105 BEAS-
2B cells were seeded onto a 60-mm culture plate. After
24 h, the pEGFPN1-ECPsp and siRNA (against STAT1
or STAT2, final concentration: 50 nM) were added into
200 μl jetPRIMEW buffer (Polyplus-transfection) and
mixed by pipetting. Then, 8 μl jetPRIMEW reagent was
added. The transfection mixture was gently vortexed,
and incubated at room temperature. After 15 min, the
transfection mixture was added drop-wise to the cells
and incubated at 37°C. The original medium was
replaced by fresh one at 24 h post-transfection. After
additional 24 h, the cell lysates were harvested for West-
ern blotting.
RNA extraction and cDNA preparation
Total RNA from BEAS-2B cells was isolated using TRI-
zol reagent (Invitrogen, USA). Cells that had been cul-
tured in a 100-mm dish were washed with cold PBS.
TRIzol reagent (1 ml) was added, and the cells were
lysed by pipetting the mixture up and down several
times. The cell lysate was then transferred to a 1.5-ml
microcentrifuge tube. After the addition of 300 μl of
cold chloroform (Sigma, USA), the lysate was gently
mixed for 15 seconds, incubated on ice for 15 min, and
then centrifuged at 10,000 ×g at 4°C for 15 min. The
RNA, which remained exclusively in the aqueous phase,
was transferred to a new tube. An equal volume of 100%
isopropanol was then added and mixed gently by invert-
ing the microcentrifuge tube repeatedly. The precipi-
tated RNA was recovered by centrifugation at 12,000
rpm for 15 min at 4°C. After removal of the supernatant,
the RNA pellet was washed twice with 75% ethanol dis-
solved in diethylpyrocarbonate (DEPC)-treated water
and then air-dried. The RNA was dissolved in sterile
DEPC-treated water. RT-PCR was used to determine
gene expression based on the level of RNA abundance.
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(MDBio, Taiwan) were mixed in DEPC-treated water
and heated at 70°C for 5 min. The reverse transcription
mixture containing 5 μl of Moloney Murine Leukemia
Virus (M-MLV) 5× reaction buffer (Promega, USA), 5 μl
of 2.5 mM dNTP (2.5 mM each of dATP, dTTP, dCTP,
and dGTP; Protech, Taiwan), 1 μl of M-MLV reverse
transcriptase (Promega, USA), and DEPC-treated water
added to a final volume of 20 μl. The cDNA was gener-
ated at 42°C.
Semi-quantitative RT-PCR
Coding regions of the genes CCL5, CXCL10, CXCL11,
CXCL16, STAT1, STAT2, and GAPDH were amplified





CXCL16-R’ (tccaggaaaggagctggaac), STAT1-F’ (tgcgcgcag-
aaaagtttcat)/STAT1-R’ (ggattcaaccaaaggagcag), STAT2-F’
(ccagaactggcaggaagctg)/STAT2-R’ (atgtcccggcagaatttccg),
and GAPDH-F’ (accacagtccatgccatcac)/GAPDH-R’ (tcca
ccaccctgttgctgta), respectively. cDNA (1 μl) was used as
the template and was mixed with 0.5 μl of each primer
(10 μM), 2 μl of dNTP (Protech, Taiwan), 0.25 μl of
GoTaq Flexi DNA polymerase (5 U/μl; Promega, USA),
4 μl of 5× Colorless GoTaq reaction buffer (Promega,
USA), 1.2 μl of 25 mM MgCl2, and sterile deionized
water to a final volume of 20 μl. The sample was heated
at 95°C for 5 min, followed by 30 cycles, each compris-
ing 95°C for 30 sec, 55°C for 30 sec, and 72°C for 30 sec,
and one cycle of 72°C for 10 min in a thermocycler
(Multigene, USA).
DNA microarray analysis
The Human Whole Genome OneArrayW v5 (HOA;
Phalanx Biotech Group, Taiwan) has in total 30,275
DNA oligonucleotide probes, and each probe has 60
nucleotides in the sense strand. Of these probes, 29,187
probes correspond to the annotated genes in the RefSeq
v38 and Ensembl v56 databases. Furthermore, 1,088
control probes are also included for monitoring the sam-
ple quality and the hybridization process. Fluorescent
aRNA targets were prepared from 1.0 μg total RNA
samples using OneArrayW Amino Allyl aRNA Amplifica-
tion Kit (Phalanx Biotech Group, Taiwan) and Cy5 dyes
(Amersham Pharmacia, Piscataway, NJ, USA). Fluores-
cent targets were hybridized to the Human Whole Gen-
ome OneArrayW with Phalanx hybridization buffer using
Phalanx Hybridization System. After 16-hr hybridization
at 50°C, non-specific binding targets were washed away
by three different washing steps (Wash I: at 42°C for 5
min; Wash II: at 42°C for 5 min and subsequent one at25°C for 5 min; and Wash III: rinsing the chips for 20
times), and the slides were dried by centrifugation and
scanned by an Axon 4000B scanner (Molecular Devices,
Sunnyvale, CA, USA). The Cy5 fluorescent intensities of
each spot were analyzed by GenePix 4.1 software (Mo-
lecular Devices). The signal intensity of each spot was
loaded into the Rosetta Resolver SystemW (Rosetta Bio-
software) for data analysis [43]. The error model of the
Rosetta Resolver SystemW removed both systematic and
random errors from the data. We filtered out spots for
which the flag was less than zero. Spots that passed
the criterion for further consideration were normalized
using the 50% media scaling normalization method.
The technical repeat data were tested by calculating
the Pearson correlation coefficient to assess reproduci-
bility (r >0.975). To identify the differentially expressed
genes, we calculate the log2 ratio of the normalized in-
tensity of treatment sample over intensity of control
sample as follows,
R ¼ log2 It=Icð Þ
where It is one probe intensity of the treatment sample,
Ic is one probe intensity of control sample. If a probe P’s
R value is bigger than the threshold (usually set as 1),
P is regarded as different expression on treatment and
control. Furthermore we can calculate the p-value p
(differential expression) to test the statistical signifi-
cance of R, which means the probability of null hypoth-
esis that treatment sample and control sample are not
differential expression for one probe. The detailed pro-
cedure to estimate p is formally described in [43]. In
our implementation, the spots with p <0.05 and R ≥1
were identified as differentially expressed genes for fur-
ther pathway analysis. The DNA microarray data has
been submitted to and approved by the Gene Expres-
sion Omnibus Database (GEO) with an accession num-
ber of GSE39122.
String
According to the gene expression profiles derived from
DNA microarray, 93 genes upregulated more than 2-fold
(log2 ≥1) and with the statistic p less than 0.05 were
selected and assembled as a gene expression subdataset
(Table 1). The functional linkage network was generated
using STRING 9.0 database [44]. The gene symbols
listed in the gene expression subdataset were input into
the frame of “multiple names” in STRING and the or-
ganism was set Homo sapiens. After executing the
search, STRING would show the possible genes we input
and we had to select correct ones. Then, the functional
linkage could be generated using the default setting.
Within this completely functional network, the evident
area of dense interconnections could be identified. In
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in the dense area, there are 618 edges to connect at least
one of the 40 nodes. Although only 43.1% (40/93) of
nodes are located in the dense area, there are 91.42%
(618/676) edges to connect the nodes in dense area with
other nodes.
Furthermore, to analyze the relationship of the func-
tional network, and the TGF-α/EGFR pathway which we
discovered previously [22], the genes within the evident
area, TGF-α and EGFR were input into STRING again.
The setting of STRING database is also default. Then,
the functional network linked evident area and TGF-α/
EGFR pathway could be generated. The figures presented
here are redrawn using Cytoscape software which could
calculate the numbers of nodes and edges efficiently.
NOA
The NOA (http://app.aporc.org/NOA) database was
designed for identifying the enrichment of gene ontol-
ogy based on biological networks as classified by sys-
tems biology [24]. According to microarray data
(Table 1), the 93 genes of interest were input into and
analyzed by the NOA server to determine the relation-
ship of network ontology.
Western blotting
After SDS-PAGE analysis, the proteins were transferred
onto a polyvinylidene fluoride (PVDF) membrane (Pall,
Pensacola). The membrane was incubated in 5% fetal
bovine serum (FBS) in PBST (1X PBS and 0.1% Tween
20) at room temperature for 1 h and then the diluted
antibody (anti-STAT1 mAb, 1:2,500 or anti-STAT2 mAb,
1:2,500, Santa Cruz, USA) in 5% FBS/PBST was added
to react with the target proteins with shaking at 4°C for
16 h. The membrane was washed with PBST three times
for 15 min each. The secondary antibody (anti-rabbit
IgG conjugated with HRP, 1:5,000, Jackson, USA) was
diluted in 3% Milk/PBST with shaking at 25°C. After
1.5 h, the membrane was washed with PBST for three
times and the target protein was visualized by addition
of the mixture of reagents A and B (Pierce) to the PVDF
membrane, and exposed by the ImageQuantTM LAS
4000 (GE Healthcare).
Macrophage migration assay
Migration assays were performed in Transwell plates
(Corning Costar, USA) with a 6.5-mm diameter and an
8-μm pore size for the membrane. Conditioned
medium was prepared before adding RAW 264.7 cells
into the top well. The BEAS-2B cells were seeded in
60-mm dishes. After 24 h, both plasmids (pEGFP-C1
and pEGFP-N1-ECPsp) were transfected into BEAS-2B
cells (as described above) for 6 h. The culture medium
containing the transfection mixture was removed, andfresh RPMI-1640 medium supplemented with 10% FBS
was added for a further 18-h incubation at 37°C in a
humidified 5% CO2 incubator. The culture medium
was removed, and fresh serum-free RPMI-1640 was
added prior to incubation at 37°C for 24 h. Three hun-
dred microliters of the serum-free medium was col-
lected, centrifuged to remove the debris, and then
transferred into the bottom wells. At the same time,
1.5 × 105 RAW 264.7 cells were transferred to each
top well. After incubation for 8 h at 37°C, cells in the
top wells were fixed using 3.7% formaldehyde for 5
min and then stained with 0.05% crystal violet for 30
min, with three further rinses with PBS. The number
of cells migrating to the lower membrane surface was
counted, and these data were used for further two-
tailed student’s t test analysis.Additional file
Additional file 1: Figure S1. The mRNA and protein levels of STAT1
and STAT2 were upregulated by ECPsp. The protein levels of STAT1 (A)
and STAT2 (B), and the mRNA levels of STAT1 (C) and STAT2 (D) were
analyzed using Western blotting and semi-quantitative RT-PCR,
respectively. (**, p < 0.01; * p< 0.05).
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